Medical and pharmacologic management of upper extremity neuropathic pain syndromes

Journal of Hand Therapy

Volumn 10, Issue 2, 1997, Pages 96-109

  Mackin, Glenn A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; GABAPENTIN; TRAMADOL;

ARTICLE; COST CONTROL; HUMAN; MEDICAL SPECIALIST; NERVE DECOMPRESSION; NEUROPATHY; NEUROPHYSIOLOGY; PAIN; TREATMENT PLANNING;

EID: 0030915623     PISSN: 08941130     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0894-1130(97)80064-6     Document Type: Article

References (88)

1. Portenoy RK: Neuropathic pain. In Portenoy RK, Kanner RM (eds.): Pain Management: Theory and Practice. Philadelphia, Davis, 1996, pp. 83-125.
2. Jupiter JB, Seiler JG, Zienowicz R: Sympathetic maintained pain (causalgia) associated with a demonstrable peripheral-nerve lesion: operative treatment. JBJS 76A:1376-1384, 1994.
3. Waldman SD, Winnie AP: Interventional Pain Management. Philadelphia, W.B. Saunders, 1996.
4. Lankford LL: Reflex sympathetic dystrophy. In Hunter JM, Mackin EJ, Callahan AD (eds.): Rehabilitation of the Hand, 4th ed. St. Louis, Mosby, 1995, pp. 779-815.
5. Bonica JJ: Causalgia and other reflex sympathetic dystrophies. In Bonica JJ (ed.): The Management of Pain, 2nd ed. Philadelphia, Lea & Febinger, 1990, pp. 220-243.
6. Mackinnon S: Double and multiple "crush" syndromes: double and multiple entrapment neuropathies. Hand Clinics 8:369-390, 1992.
7. Amato AA, Gronseth GS, Callerame KJ, et al: Tomaculous neuropathy: a clinical and electrophysiological study in patients with and without 1.5-Mb deletions in chromosome 17p11.2. Muscle & Nerve 19:16-22, 1996.
8. Mackin GA: Diagnosis of patients with peripheral nerve disease. Clin Pod Med Surg 11:545-569, 1994.
9. Schott GD: Visceral afferents: their contribution to 'sympathetic dependent' pain. Brain 117:397-413. 1994.
10. Zimmerman M: Peripheral and central nervous mechanisms of nociception, pain and pain therapy. Adv Pain Res Ther 7:57, 1984.
11. Roberts WJ: A hypothesis on the physiological basis for causalgia and related pains. Pain 24:297-311, 1986.
12. Loeser JD: Concepts of pain. In Stanton-Hicks M, Boas R (eds.): Chronic Low Back Pain. New York, Raven Press, 1982.
13. Dotson RM: Causalgia - reflex sympathetic dystrophy - Sympathetically maintained pain: myth and reality. Muscle & Nerve 16:1049-1055, 1993.
14. Stanton-Hicks M, Jänig W, Hassenbruch S, et al: Reflex sympathetic dystrophy: changing concepts and taxonomy. Pain 63:127-133, 1995.
15. Rowbotham MC: Chronic pain: from theory to practical management. Neurology 45(suppl. 9):S5-S10, 1995.
16. Mitchell SW: On the diseases of nerves resulting from injuries in wartime; contributions relating to the prevention and causation of disease, and to camp disease. In Flint A (ed.): United States Sanitary Commission Memoirs. New York, 1867.
17. Sudeck PHM: Über die acute entzundliche knockenatrophie. Arch Clin Khir 62:147, 1900.
18. Blumberg H: A new clinical approach for diagnosing reflex sympathetic dystrophy. In Bond MR, Charlton JE, Woolf CJ (eds.): Proceedings of the VIth World Congress on Pain. Amsterdam, Elsevier, 1991, pp. 685-691.
19. Gibbons JJ, Wilson PR: RSD score: criteria for the diagnosis of reflex sympathetic dystrophy and causalgia. Clin J Pain 8:260-263, 1992.
20. Janig W, Blumberg H, Boas RA, et al: The reflex sympathetic dystrophy syndrome: consensus statement and general recommendations for diagnosis and clinical research. In: Bond MR, Charlton JE, and Woolf CJ (eds.): Proceedings of the VIth World Congress on Pain. Amsterdam, Elsevier, 1991, pp. 373-376.
21. American Association of Electrodiagnostic Medicine: Guidelines in electrodiagnostic medicine. Muscle & Nerve 15:229-253, 1992.
22. Mackin GA: Electrophysiologic testing of injured and regenerating nerves. In: Hunter JM, Schneider LH, Mackin EJ (eds): Tendon and Nerve Surgery in the Hand - A Third Decade. St. Louis, Mosby, 1997, pp. 31-45.
23. Walsh MT: Therapist's management of reflex sympathetic dystrophy. In Hunter JM, Mackin EJ, Callahan AD (eds.): Rehabilitation of the Hand, 4th ed. St. Louis, Mosby, 1995, pp. 817-842.
24. Bell-Krotoski J, Weinstein S, Weinstein C: Testing sensibility, including touch-pressure, two-point discrimination, point-localization and vibration. J Hand Ther 6:114-123, 1993.
25. Moberg E: Nerve repair in hand injury: an analysis. Surg Clin North Am 48:985-991, 1968.
26. Dellon AL: The moving two-point discrimination test: clinical evaluation of the quickly-adapting fiber/receptor system. J Hand Surg 3A:474-481, 1978.
27. Bell-Krotoski J: Advances in sensibility evaluation. Hand Clinics 7:527-546, 1991.
28. Finch PM, Taylor JR: Functional anatomy of the spine. In: Waldman SD, Winnie AP (eds.): Interventional Pain Management. Philadelphia, Saunders, 1996, p. 53.
29. Gracely RH, Lynch SA, Bennett GJ: Painful neuropathy: altered central processing maintained dynamically by peripheral input. Pain 51:175-194, 1992.
30. LaMotte RH, Whain CN, Simone DA, et al: Neurogenic hyperalgesia: psychophysical studies. J Neurophysiol 66:190-211, 1992.
31. Choinere M, Amsel R: A visual analogue thermometer for measuring pain intensity. J Pain Symptom Mgmt 11:299-311, 1996.
32. Holroyd KA, Holm JE, Keefe FJ, et al.: A multi-center evaluation of the McGill Pain Questionnaire: results from more than 1700 chronic pain patients. Pain 48:301-311, 1992.
33. Gonzales GR: Central pain: diagnosis and treatment strategies. Neurology 45(Supplement 9):S11-S16, 1995.
34. Fruhstorfer H, Lindblom U, Schmidt WG: Method for quantitative estimation of thermal thresholds in patients. J Neurol Neurosurg Psychiatry 39:1071-1075, 1976.
35. Yarnitsky D, Sprecher E: Thermal testing: normative data and repeatability for various algorithms. J Neurol Sci 125: 39-45, 1994.
36. Tjon-A-Tsien AM, Gert van Dijk J, van der Velde, et al.: Determinants of vibration perception thresholds in IDDM and NIDDM patients. Diabetes Res Clin Pract 27:211-219, 1995.
37. Report and recommendations of the San Antonio conference on diabetic neuropathy. Ann Neurol 24:99-104, 1988.
38. Verdugo RJ, Ochoa JL: Use and misuse of conventional electrodiagnosis, quantitative sensory testing, thermography and nerve blocks in the evaluation of painful neuropathic syndromes. Muscle Nerve 16:1056-1062, 1993.
39. Verdugo RJ, Ochoa JL: Quantitative somatosensory thermotest: a key method for functional evaluation of small calibre afferent channels. Brain 115:893-913, 1992.
40. Claus D, Hilz MJ, Hummer I, Neundorfer B: Methods of measurement of thermal thresholds. Acta Neurol Scand 76: 288-296, 1987.
41. Levoska S, Keinanen-Kiukaanniemi S, Bloigu R: Repeatability of measurement of tenderness in the neck-shoulder region by a dolorimeter and manual palpation. Clin J Pain 9:229-235, 1993.
42. Cline MA, Ochoa JL, Torebjörk HE: Chronic hyperalgesia and skin warming caused by sensitized C nociceptors. Brain 112:1317-1331, 1989.
43. Woolf CJ: The dorsal horn: State-dependent sensory processing and the generation of pain. In Wall PD, Melzack R, (eds.): Textbook of Pain, 3rd ed. Edinburgh, Churchill-Livingstone, 1994, pp. 101-112.
44. Torebjörk E: Human microneurrography and intraneural microstimulation in the study of the neuropathic pain. Muscle & Nerve 16:1063-1065, 1993.
45. Kozin F, McCarty DJ, Sims J, et al.: The reflex sympathetic dystrophy syndrome: I. Clinical and histologic studies: evidence for bilaterality, response to corticosteroids and articular involvement. Am J Med 60:321-331, 1976.
46. Cremer SA, Maynard F, Davidoff G: The reflex sympathetic dystrophy syndrome associated with traumatic myelopathy. Pain 37:187-192, 1989.
47. Cardoso F, Jankovic J: Peripherally induced tremor and parkinsonism. Arch Neurol 52:263-270, 1995.
48. Ochoa JL, Verdugo RJ: Reflex sympathetic dystrophy: a common clinical avenue for somatoform expression. Neurol Clin 13:351-363, 1995.
49. Sutton IR, Cousins MJ: Anesthetic techniques for pain control. In Portenoy RK, Kanner RM (eds.): Pain Management: Theory and Practice. Philadelphia, Davis, 1996, pp. 277-289.
50. Blumberg H, Griesser HJ, Hornyak M: New viewpoints on the clinical picture, diagnosis and pathophysiology of reflex sympathetic dystrophy (Sudeck's disease) Unfallchirurgie 16(2):95-106. (German; English translation of abstract on MedLine).
51. Wahren LK, Torebjork E: Quantitative sensory tests in patients with neuralgia 11 to 25 years after injury. Pain 48: 237-244, 1992.
52. Schiffenbauer J, Fagien M: Reflex sympathetic dystrophy involving multiple extremities. J Rheumatol 20:165-169, 1993.
53. Bentley JB, Hameroff SR: Diffuse reflex sympathetic dystrophy. Anesthesiol 53:256-257, 1980.
54. Schwartzman RJ: Reflex sympathetic dystrophy. Curr Opin Neurol Neurosurg 6(4):531-536, 1993.
55. Thomas PK, Ochoa J: Clinical features and differential diagnosis. In Dyck PJ, Thomas PK, et al. (eds.): Peripheral Neuropathy, 3rd ed. Philadelphia, Saunders, 1993, p. 764.
56. Tennant F, Robinson D, Sagherian A, et al.: Chronic opioid treatment of intractable, non-malignant pain. NIDA Research Monograph 81:174-180, 1988.
57. Haddox JD: Coanalgesic agents. In Raj PP: Pain Medicine: A Comprehensive Review. St. Louis, Mosby, 1996, pp. 142-153.
58. Willner C, Low PA: Pharmacologic approaches to neuropathic pain. In Dyck PJ, Thomas PK, et al. (eds.): Peripheral Neuropathy, 3rd ed. Philadelphia, Saunders, 1993, pp. 1709-1720.
59. Blackburn WD: Management of osteoarthritis and rheumatoid arthritis: prospects and possibilities. Am J Med 100(2A):24S-30S, 1996.
60. Polisson R: Nonsteroidal anti-inflammatory drugs: practical and theoretical considerations in their selection. Am J Med 100(2A):31S-36S, 1996.
61. Max MB, Culnane M, Schafer SC, et al.: Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 37:589-594, 1987.
62. Feinmann C: Pain relief by antidepressants: possible modes of action. Pain 23:1-8, 1985.
63. Max MB, Lynch SA, Muir J, et al.: Effects of desipramine, amitriptyline and fluoxetine on pain in diabetic neuropathy. N Engl J Med 326:1250-1256, 1992.
64. Sindrup SH, Gram LF, Brosen K, et al.: The selective serotonin reuptake inhibitor paroxetine is effective in treatment of diabetic neuropathy symptoms. Pain 42:135-144, 1990.
65. McQuay H, Carroll D, Jadad AR, et al: Anticonvulsant drugs for management of pain: a systematic review. BMJ 311:1047-1052, 1995.
66. Rull JA, Quibrera R, Gonzalez-Milan HH, et al.: Sympatomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol): double blind cross-over trial. Diabetologia 5:215-218, 1969.
67. Weinberger J, Nicklas WJ, Berl S: Mechanism of action of anticonvulsants. Neurology 26:162, 1976.
68. Burchiel KJ: Carbamazepine inhibits spontaneous activity in experimental neuromas. Exp Neurol 102:249-253, 1988.
69. Bouckoms AJ, Litman RE: Clonazepam in the treatment of neuralgic pain syndrome. Psychosomatics 26:933-936, 1985.
70. Galer BS: Neuropathic pain of peripheral origin: advances in pharmacologic treatment. Neurology 45(suppl 9):S17-S25, 1995.
71. Dejgärd A, Peterson P, Kastrup J: Mexilitene for treatment of chronic painful diabetic neuropathy. Lancet 1:9-11, 1988.
72. The Capsaicin Study Group. Treatment of painful diabetic neuropathy with topical capsaicin: a multicenter, double-blind, vehicle-controlled study. Arch Int Med 151:2225-2229, 1991.
73. Low PA, Opfer-Gehrking TL, Dyck PJ, et al.: Double-blind, placebo-controlled study of the application of capsaicin cream in chronic distal painful polyneuropathy. Pain 62: 163-168, 1995.
74. Watson CPN, Tyler KL, Bickers DR, et al.: A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Therapeutics 15:510-526, 1993.
75. Byas-Smith MG, Max MB, Muir J, et al.: Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage "enriched enrollment" design. Pain 60: 267-274, 1995.
76. Abram SE, Lightfoot RW: Treatment of longstanding causalgia with prazosin. Reg Anes 6:79-81, 1981.
77. Ghostine SY, Comair YG, Turner DM, et al.: Phenoxybenzamine in the treatment of causalgia. J Neurosurg 60:1263-1268, 1984.
78. Kozin F, McCarty DJ, Sims J: The reflex sympathetic dystrophy syndrome. Am J Med 60:321-31, 1976.
79. Gobelet C, Waldburger M, Meier JL: The effect of adding calcitonin to physical treatment on reflex sympathetic dystrophy. Pain 48:171-175, 1992.
80. Jaeger H, Maier C: Calcitonin in phantom limb pain: a double blind study. Pain 48:21-27, 1992.
81. Lipman AG: Clinically relevant differences among the opioid analgesics. Am J Hosp Pharm 47:S7-S13, 1990.
82. Raffa RB, Fridericks E, Reimann W, et al.: Complementary and synergistic antinociceptive interaction between enantomers of tramadol. J Pharmacol Exp Ther 267:331-340, 1993.
83. Driessen B, Riemann W: Interaction of the central analgesic, tramadol, with the uptake and release of 5-hydroxytryptamine in the rat brain in vitro. Br J Pharmacol 105:147-151, 1992.
84. Rauck RL, Rouff GE, McMillen JI: Comparison of tramadol and acetaminophen with codeine for long-term pain management in elderly patients. Curr Ther Res 55:1417-1431, 1994.
85. Mellick LB, Mellick GA: Successful treatment of reflex sympathetic dystrophy with gabapentin (letter). Am J Emerg Med 13:96, 1995.
86. Mellick GA, Seng ML: The use of gabapentin in the treatment of reflex sympathetic dystrophy and a phobic disorder. AJPM 5:7-9, 1995.
87. Rosner H, Rubin L, Kestenbaum A: Gabapentin adjunctive therapy in neuropathic pain states. Clin J Pain 12:56-58, 1996.
88. deJong RH: Neurontin: pie in the sky or pie on the plate? Pain Digest 6:143-144, 1996.